Titlebook: Drug Adherence in Hypertension and Cardiovascular Protection; Michel Burnier Book 2018 Springer International Publishing AG, part of Sprin

Facilities

Accord

Determinants and Barriers to Adherence in Hypertensions to adherence in hypertension utilizing the WHO Multidimensional Adherence Model classification, showing in which phase of the adherence process they intervene. We will review how these barriers may complicate the therapeutic history of a hypertensive patient based on a clinical case.

NUL

Vorlesungen über Topographische Anatomies and claims. Objective dosing history data supports faster, smarter clinical drug development and avoids wasting time and money in medical practice. Failure to monitor individual dosing patterns means discounting the impact of poor adherence—the factor that is emerging as the single greatest cause of failed drug therapy.

暖昧關(guān)系

顯而易見

2366-4606 in clinical trials..Highlights the role of a multidisciplina.This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherenc